Cardiovascular Pharmacotherapy
Showing 24 of 1176 results
ESC Journals
ST-elevation myocardial infarction following de-escalation to aspirin monotherapy: evidence of residual platelet function MRP4 overexpression dependent case report
22 May 2026
ESC Journals
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib
21 May 2026
ESC Journals
Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report
14 May 2026
ESC Journals
From angiography-derived physiology guided PCI to INOCA treatment and to coronary sinus reducer: navigating multiple pathophysiological targets in a single patient: a case report
14 May 2026
ESC Journals
Feasibility of hypnosis for analgosedation during atrial fibrillation ablation, including pulsed field and radiofrequency techniques: a pilot study
14 May 2026
ESC Journals
Disturbed flow induced targeting of nanomedicine to endothelial cells for effective atherosclerosis therapy
13 May 2026
Congress Session
Heart failure with preserved ejection fraction subtypes: pathophysiology and treatments
11 May 2026
Congress Session
Congress Session
Congress Session
Congress Session
ESC Journals
Inhibition of the programmed death protein 1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischaemia
22 April 2026
ESC Journals
Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction
21 April 2026
ESC Journals
Fat, muscle, and anti-obesity medications in cardiovascular disease prevention
31 March 2026
ESC Journals
Development and validation of clinical prediction models for personalized renal function monitoring in people with heart failure in primary care: the RENAL-HF study protocol
31 March 2026
ESC Journals
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
31 March 2026
ESC Journals
Troponin T/I discordance in immune checkpoint inhibitor myositis in a patient with ischaemic cardiac disease: a case report
18 March 2026
ESC Journals
Efficacy of ranolazine in reducing complex premature ventricular contractions in a patient with mitral valve prolapse: a case report
18 March 2026
ESC Journals
VEGF-C-mediated cardiac lymphangiogenesis promotes inflammation resolution in autoimmune acute myocarditis in mice
17 March 2026
ESC Journals
Unravelling mitochondrial succinate transport during I/R and devising a novel transport inhibitor show promise for targeting I/R injury, but will efficacy remain under more human-like conditions present during I/R?
17 March 2026
ESC Journals
ESC Journals
Further mystification of <em>SCN5A</em> phenotypes: sodium channel blockade in individuals with loss-of-function sodium channel mutations dangerous or helpful?
11 March 2026
ESC Journals
Inflammation-associated rapidly progressive coronary artery disease: a case report
10 March 2026
ESC Journals
